BIGBEAR
PHARMACEUTICAL
Erdafitinib exerts its antitumor effect by selectively inhibiting FGFR1‑4, blocking downstream signaling to suppress tumor cell proliferation and survival.
AuthenticGuaranteeFast DeliveryPrivacy On August 29, Genzo Pharmaceuticals announced that it has filed a supplemental New Drug Application (NDA) with the US Food and Drug Administration (FD···【More】
Update: 07 Apr,2026Source: BigbearViews: 84
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
